Legal Representation
Attorney
Daniel Chalker
USPTO Deadlines
Next Deadline
1948 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20250429)
Due Date
April 29, 2031
Grace Period Ends
October 29, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
16 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Apr 29, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Apr 29, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Apr 6, 2025 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Apr 6, 2025 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Feb 22, 2025 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Dec 10, 2024 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Feb 21, 2025 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Dec 10, 2024 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Jul 9, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| May 14, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| May 14, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Apr 24, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Apr 8, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Mar 25, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 31, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Oct 28, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Medical scientific research testing, research and development services in the fields of immune system modeling, antibodies, pharmaceuticals, biologics, immunotherapies, and cell therapies; Drug discovery services; Biotechnology research and development services, namely, providing screening and analysis of immune responses, antibodies, human cells, and pharmaceutical and biologic therapies
First Use Anywhere:
20230500
First Use in Commerce:
20230500
Additional Information
Pseudo Mark
SHIELD TX
Classification
International Classes
042